Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor
about
Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloofA soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonistCloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3The biological functions of T helper 17 cell effector cytokines in inflammationAnti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunityStructure of IL-22 bound to its high-affinity IL-22R1 chainInterleukin-24 and its receptorsInterleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell TransplantationInterleukin-22 Signaling in the Regulation of Intestinal Health and DiseaseCrystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanismCrystal structure of a soluble decoy receptor IL-22BP bound to interleukin-22A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraThe Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasisThe T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chainsMaturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytesInvolvement of the IL-22/REG Ialpha axis in ulcerative colitisCloning and characterization of mouse IL-22 binding proteinInterleukin-10 suppression of myeloid cell activation--a continuing puzzle.IL-22 negatively regulates Helicobacter pylori-induced CCL20 expression in gastric epithelial cellsJAK2 V617F constitutive activation requires JH2 residue F595: a pseudokinase domain target for specific inhibitorsInterleukin 22 attenuated angiotensin II induced acute lung injury through inhibiting the apoptosis of pulmonary microvascular endothelial cellsHigh systemic levels of interleukin-10, interleukin-22 and C-reactive protein in Indian patients are associated with low in vitro replication of HIV-1 subtype C virusesHypothermia Promotes Interleukin-22 Expression and Fine-Tunes Its Biological Activity.Interleukin-22 suppresses the growth of A498 renal cell carcinoma cells via regulation of STAT1 pathway.IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway diseaseIL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signalingInterleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2.Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions.Multiparameter grouping delineates heterogeneous populations of human IL-17 and/or IL-22 T-cell producers that share antigen specificities with other T-cell subsets.Structural analysis of cytokines comprising the IL-10 familyRORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cellsGenetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphomaTLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127+ immune cells in spleen and mucosa.New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domainIL-22 mediates goblet cell hyperplasia and worm expulsion in intestinal helminth infection.The role of cytokines and their signaling pathways in the regulation of immunity to Toxoplasma gondii.IL-20: a new target for the treatment of inflammatory skin disease.IL22/IL-22R pathway induces cell survival in human glioblastoma cells.Interleukin-22: immunobiology and pathology.STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease?
P2860
Q21246039-789A514C-485F-4B2F-ABB9-AD8C52CB6E86Q24291506-ED169707-0C70-4861-9801-C2566854678AQ24535580-42FABDD9-BB55-4A96-A59F-0C8A1D15AFFBQ24614431-93792D40-4675-4F5C-91A2-002DC2C382AFQ24642507-3DFF4C7A-9320-490F-B343-6774B5F4FE30Q24656543-DAC082C9-1459-4F0F-885D-85F6E61B1CC8Q24683032-F8E97CB8-BFC0-4C7A-88D5-ACC09C5C8B18Q26752528-AB3E1A97-EF20-494E-BF9C-76047B55EA68Q26770224-0510DA17-05A6-4509-BA0F-5C937FC9396FQ27651398-A1EE972D-D50A-4E1F-BD0F-2A33CBCF08C5Q27654095-57E619C4-29BE-4900-8572-A093179CE9DCQ28241887-C92F1E34-874E-4AE3-9F0F-189D543643C5Q28261494-CBB673EB-D7E4-41E7-8217-FBD7E249BE82Q28265025-CF172D17-5B57-4957-B31B-2AB21B2B064DQ28269054-D8005FE8-44D1-4F16-BE4D-F7648AE790E8Q28270049-C8097375-9095-4712-98AC-6B788E845AA5Q28509977-246E3248-1D25-49FB-B3C0-498029627B2AQ33340529-1237D87B-8CA4-40E8-950A-949C9A44D028Q33604771-E936E3B4-66D3-4B84-A72C-0A3F43DE6D9CQ33618917-13749479-81B0-42C2-AC53-62B56950010DQ33708468-8694C820-6420-433A-9F7B-A6C4925ABD98Q33736978-637A60C6-8A83-4699-B643-349C07033F26Q33849531-92109363-29BF-4EA2-8ACA-F99E68A99D5EQ33916153-FF5AAE75-6E2F-4C3C-A6DB-AF907C97D01AQ33971114-7E7CF1D6-A8E8-46CF-B27B-7A00742298B2Q34051942-A1CFC771-F1CF-4919-AB75-B7EACAF809D9Q34101518-09D8E158-DE9E-450A-B21F-A1866C07C851Q34152063-DE796843-6201-4AC2-9579-41E0477CC8D4Q34193939-5A2E92ED-18D3-4ED5-A292-4B0D928FE732Q34384616-39A88BBA-660A-4AB6-895C-7AD55822122EQ34441341-60D6EEA9-87D1-4F51-B19A-7BBEDB927F18Q34454590-BD303FCA-9CEE-4782-B8C0-51B0FCBBCB8EQ34694834-EDB1A051-10B2-440B-B2B6-59EC55B23214Q34994147-C8E503D3-7729-4E07-8593-D660DD7335D1Q35018086-B43139E4-77DA-4132-8729-20DB4AA58462Q35027528-26EA17D0-62C1-49C8-9005-763E6644FEC2Q35095128-9D7FCEDF-D83F-46DE-9BF5-5F7CFF0A8716Q35203455-AFE0E604-6B1D-4FCC-B2EE-4ED1F72BF3A1Q35530956-A3F1F248-A066-4C65-810D-DEBCC8670986Q35589806-BF6BEDC4-E12B-47EA-A1FD-050801130DD3
P2860
Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Human interleukin-10-related T ...... hepatocyte-stimulating factor
@ast
Human interleukin-10-related T ...... hepatocyte-stimulating factor
@en
Human interleukin-10-related T ...... hepatocyte-stimulating factor
@en-gb
Human interleukin-10-related T ...... hepatocyte-stimulating factor
@nl
type
label
Human interleukin-10-related T ...... hepatocyte-stimulating factor
@ast
Human interleukin-10-related T ...... hepatocyte-stimulating factor
@en
Human interleukin-10-related T ...... hepatocyte-stimulating factor
@en-gb
Human interleukin-10-related T ...... hepatocyte-stimulating factor
@nl
prefLabel
Human interleukin-10-related T ...... hepatocyte-stimulating factor
@ast
Human interleukin-10-related T ...... hepatocyte-stimulating factor
@en
Human interleukin-10-related T ...... hepatocyte-stimulating factor
@en-gb
Human interleukin-10-related T ...... hepatocyte-stimulating factor
@nl
P2093
P2860
P921
P3181
P356
P1476
Human interleukin-10-related T ...... hepatocyte-stimulating factor
@en
P2093
E Van Roost
J C Renauld
L Dumoutier
P2860
P304
P3181
P356
10.1073/PNAS.170291697
P407
P577
2000-08-29T00:00:00Z